Table 2.

Donor Treg DLI product characteristics

Cell dosesMedian (range)
Starting apheresis viable TNC 2.43 × 1010 (0.99 × 1010, 5.95 × 1010
MRD collected locally 2.83 × 1010 (1.47 × 1010, 3.53 × 1010
URD from collection site 2.20 × 1010 (0.99 × 1010, 5.95 × 1010
% Treg of apheresis 3.40% (1.90, 5.26) 
Final viable TNC after selection 1.08 × 108 (0.54 × 108, 3.07 × 108
Viable TNC infused per kg 
Dose level A 0.1 × 106/kg 
Dose level B 0.3 × 106/kg 
Dose level C 1.00 × 106/kg (0.58 × 106, 1 × 106
Treg cells infused per kg 
Dose level A 9.19 × 104/kg (6.68 × 104, 9.47 × 104
Dose level B 2.69 × 105/kg (2.49 × 105, 2.87 × 105
Dose level C 7.60 × 105 (5.11 × 105, 9.31 × 105
Selection efficiency 
CD8+ log depletion  4.4 (3.5, 5.1) 
CD20+ log depletion  4.4 (3.1, 5.3) 
% CD4+ CD25hi of leukocytes 92.9% (82.7, 98.1) 
% CD4+ CD25+ CD127lo of leukocytes 88.4% (66.8, 98.5) 
Treg fold enrichment 26.6 (12.7, 44) 
Treg % recovery over process 14.9% (5.6, 30.5) 
Cell dosesMedian (range)
Starting apheresis viable TNC 2.43 × 1010 (0.99 × 1010, 5.95 × 1010
MRD collected locally 2.83 × 1010 (1.47 × 1010, 3.53 × 1010
URD from collection site 2.20 × 1010 (0.99 × 1010, 5.95 × 1010
% Treg of apheresis 3.40% (1.90, 5.26) 
Final viable TNC after selection 1.08 × 108 (0.54 × 108, 3.07 × 108
Viable TNC infused per kg 
Dose level A 0.1 × 106/kg 
Dose level B 0.3 × 106/kg 
Dose level C 1.00 × 106/kg (0.58 × 106, 1 × 106
Treg cells infused per kg 
Dose level A 9.19 × 104/kg (6.68 × 104, 9.47 × 104
Dose level B 2.69 × 105/kg (2.49 × 105, 2.87 × 105
Dose level C 7.60 × 105 (5.11 × 105, 9.31 × 105
Selection efficiency 
CD8+ log depletion  4.4 (3.5, 5.1) 
CD20+ log depletion  4.4 (3.1, 5.3) 
% CD4+ CD25hi of leukocytes 92.9% (82.7, 98.1) 
% CD4+ CD25+ CD127lo of leukocytes 88.4% (66.8, 98.5) 
Treg fold enrichment 26.6 (12.7, 44) 
Treg % recovery over process 14.9% (5.6, 30.5) 

Treg defined as CD4+ CD25+ CD127lo cells.

Log depletion based on absolute numbers of cells.

or Create an Account

Close Modal
Close Modal